New York Blood Center Enterprises (NYBCe) acquired Talaris Therapeutics, Inc.’s commercial-scale cell and gene therapy development and manufacturing facilities, as well as certain technologies and equipment from Talaris in Houston, TX and Louisville, KY. The acquisition of both locations, combined with NYBCe’s Comprehensive Cell Solutions (CCS) cell sourcing and collection network, helps accelerate the delivery of a fully integrated vein-to-vein cell and gene therapy development and manufactu...